Shots: The collaboration will combine Genialis’ expressions software platform and analytics IP with Oncologie’s clinical and translational expertise to refine patient stratification methodologies The companies will initially focus on modeling […]readmore
Profound Medical’s TULSA-PRO Receives the US FDA’s 510(k) Clearance for Ablation of Prostate Tissue Published: Aug 16, 2019 | Tags: 510(k), Ablation, Clearance, Profound Medical, Prostate Tissue, Receives, TULSA-PRO, The US […]readmore
Shots: Oncologie to conduct P-II study assessing the efficacy and safety of Bavituximab in combination with Merck’s Keytruda (pembrolizumab) in patients with 1L advanced gastric or gastroesophageal cancer enrolling ~80 […]readmore
Copyright © 2020 Digiqole. All Right Reserved.